Endoscopy 2019; 51(04): S233
DOI: 10.1055/s-0039-1681869
ESGE Days 2019 ePosters
Friday, April 5, 2019 09:00 – 17:00: ERCP ePosters
Georg Thieme Verlag KG Stuttgart · New York

EVALUATION OF PREDICTORS FACTORS OF FAILURE IN ENDOSCOPIC BILIARY DRAINAGE IN MALIGNANT HILAR BILIARY STRICTURE

L Haendchen Bento
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
,
E Mendonça
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
,
B Costa Martins
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
,
R Jureidini
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
,
T Bacchella
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
,
A Safatle-Ribeiro
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
,
U Ribeiro
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
,
F Maluf-Filho
1   Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil
› Author Affiliations
Further Information

Publication History

Publication Date:
18 March 2019 (online)

 
 

    Aims:

    To evaluate the clinical success of biliary drainage by ERCP in patients with primary or secondary malignant hilar biliary stricture and to analyze the predictors factors of failure.

    Methods:

    This is a retrospective, observational study, in a tertiary oncologic center in Brazil. We included all the patients with malignant hilar biliary stricture (Bismuth ≥ II) submitted to a biliary drainage by ERCP, between January 2010 and December 2017. Clinical success was defined as a decrease in the direct bilirubin level to ≤50% of the pretreatment value within 2 weeks.

    Results:

    82 patients were included. Bismuth classification grades II, IIIA, IIIB, and IV were noted in 23.2%, 15.9%, 14.6% and 46.3%, respectively. The indication of ERCP was palliative drainage in 56.1%, cholangitis in 29.3% and in previous stent obstruction in 13.4%. About 39% of the patients had a previous stent, 35.4% had plastic stent and 3.7% had metallic stent. The mean direct bilirubin was 8.2 mg/dL.

    In 7.3% stent placement technically failed. In 20.7% one hepatic lobe was drainage, in 64.6% more than one lobe was drainage and in 7.3 the stent was placed distal to the confluence of the biliary hepatic branch. The clinical success rate was 53.7%.

    The strictures Bismuth IV were related with lower clinical success rate when compared with others strictures (Table 1).

    Tab. 1:

    Predictors of clinical failure for biliary stents

    Model and variable

    B (S.E)

    Hazard ratio (95% CI)

    P value

    Biliary strictures Bismuth IV

    1.65 (0.71)

    5.18 (1.28 – 20.88)

    0.021

    Lobes > 1 lobe

    0.84 (0.67)

    2.31 (0.62 – 8.59)

    0.213

    Cholangitis Presence

    1.42 (0.85)

    4.15 (0.78 – 22.04)

    0.095

    Bilirubin levels

    0.07 (0.04)

    1.07 (0.99 – 1.15)

    0.052

    Conclusions:

    Endoscopic biliary drainage for malignant hilar biliary stricture still has limited clinical success rate. The proximal strictures (Bismuth IV) are associated with lower clinical success rate.


    #